Macrogenics (MGNX) EBITDA Margin Growth (3y) (2015 - 2026)
Macrogenics (MGNX) EBITDA Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Macrogenics |
260.14 Mn |
193.63 Mn |
- |
-2,218.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,218.00 |
| Dec 31, 2025 |
-5,193.00 |
| Sep 30, 2025 |
8,206.00 |
| Jun 30, 2025 |
-403.00 |
| Mar 31, 2025 |
28,943.00 |
| Dec 31, 2024 |
37,197.00 |
| Sep 30, 2024 |
38,859.00 |
| Jun 30, 2024 |
-155,658.00 |
| Mar 31, 2024 |
-26,996.00 |
| Dec 31, 2023 |
-41,903.00 |
| Sep 30, 2023 |
36,675.00 |
| Jun 30, 2023 |
66,861.00 |
| Mar 31, 2023 |
96,159.00 |
| Dec 31, 2022 |
13,835.00 |
| Sep 30, 2022 |
17,926.00 |
| Jun 30, 2022 |
14,058.00 |
| Mar 31, 2022 |
-13,464.00 |
| Dec 31, 2021 |
-14,666.00 |
| Sep 30, 2021 |
23,614.00 |
| Jun 30, 2021 |
10,541.00 |
